Literature DB >> 14672399

Familial breast cancer: scope for more susceptibility genes?

Kari Hemminki1, Charlotta Granström.   

Abstract

PURPOSE: The familial risk of female breast cancer is somewhat less than 2.0 when a first-degree relative is diagnosed with breast cancer, but it is not known to what extent heritable or environmental factors explain the familial clustering. Such data would be valuable for prevention and gene identification strategies. EXPERIMENTAL
DESIGN: We used the nation-wide Swedish Family-Cancer Database on 10.2 million individuals and 190,000 mothers' and 26,000 daughters' breast cancers to calculate familial standardised incidence ratios (SIRs), for all invasive breast cancers in daughters, who were 0-66 years old. Over 5500 familial breast cancers were recorded.
RESULTS: The familial SIR for all invasive breast cancer was 1.71 by breast cancer in the mother only, 1.95 by breast cancer in a sister only, and 2.75 by breast cancer in both a mother and sister. The SIRs did not change when adjustments were done for period, age at first birth, parity, socio-economic status and region. Age difference between sisters showed a small variation in risk for breast cancer but the highest SIR was found for those whose age difference was from 6 to 10 years. Half sisters showed an excess of familial risks exactly half of full sisters, the SIR being 1.44.
CONCLUSIONS: These data suggest that familial aggregation of breast cancer is mainly due to heritable causes. Because the known susceptibility genes only explain about a quarter of the familial aggregation, the remaining majority offers a challenge to new genomic approaches.

Entities:  

Mesh:

Year:  2003        PMID: 14672399     DOI: 10.1023/B:BREA.0000003871.38587.8b

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  11 in total

1.  Epistatic interaction of Arg72Pro TP53 and -710 C/T VEGFR1 polymorphisms in breast cancer: predisposition and survival.

Authors:  Patricia Rodrigues; Jessica Furriol; Eduardo Tormo; Sandra Ballester; Ana Lluch; Pilar Eroles
Journal:  Mol Cell Biochem       Date:  2013-04-06       Impact factor: 3.396

2.  Diet and predictors of dietary intakes in women with family history of breast and/or ovarian cancer.

Authors:  Archana J McEligot; Michele Mouttapa; Argyrios Ziogas; Hoda Anton-Culver
Journal:  Cancer Epidemiol       Date:  2009-10-14       Impact factor: 2.984

3.  Germline and somatic KLLN alterations in breast cancer dysregulate G2 arrest.

Authors:  Emily A Nizialek; Charissa Peterson; Jessica L Mester; Erinn Downes-Kelly; Charis Eng
Journal:  Hum Mol Genet       Date:  2013-02-27       Impact factor: 6.150

4.  The incidence of PALB2 c.3113G>A in women with a strong family history of breast and ovarian cancer attending familial cancer centres in Australia.

Authors:  Zhi L Teo; Sarah D Sawyer; Paul A James; Gillian Mitchell; Alison H Trainer; Geoffrey J Lindeman; Kylie Shackleton; Linda Cicciarelli; Melissa C Southey
Journal:  Fam Cancer       Date:  2013-12       Impact factor: 2.375

5.  Family history of malignancies and risk of breast cancer: prospective data from the Shanghai women's health study.

Authors:  Briseis A Kilfoy; Yawei Zhang; Xiao-Ou Shu; Yu-Tang Gao; Bu-Tian Ji; Gong Yang; Hong Lan Li; Nathaniel Rothman; Wong-Ho Chow; Wei Zheng
Journal:  Cancer Causes Control       Date:  2008-06-25       Impact factor: 2.506

6.  Single nucleotide polymorphisms (SNPs) are inherited from parents and they measure heritable events.

Authors:  Kari Hemminki; Asta Försti; Justo Lorenzo Bermejo
Journal:  J Carcinog       Date:  2005-01-17

7.  Genetic predisposition of six well-defined polymorphisms in HMGB1/RAGE pathway to breast cancer in a large Han Chinese population.

Authors:  Liling Yue; Qibing Zhang; Lan He; Minglong Zhang; Jing Dong; Dalong Zhao; Hongxing Ma; Hongming Pan; Lihong Zheng
Journal:  J Cell Mol Med       Date:  2016-05-31       Impact factor: 5.310

8.  Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening.

Authors:  A Smith; A Moran; M C Boyd; M Bulman; A Shenton; L Smith; R Iddenden; E R Woodward; F Lalloo; E R Maher; D G R Evans
Journal:  J Med Genet       Date:  2006-11-01       Impact factor: 6.318

9.  Estimates of heritable and environmental components of familial breast cancer using family history information.

Authors:  E Couto; K Hemminki
Journal:  Br J Cancer       Date:  2007-05-01       Impact factor: 7.640

10.  The frequency of cancer predisposition gene mutations in hereditary breast and ovarian cancer patients in Taiwan: From BRCA1/2 to multi-gene panels.

Authors:  Pi-Lin Sung; Kuo-Chang Wen; Yi-Jen Chen; Ta-Chung Chao; Yi-Fang Tsai; Ling-Ming Tseng; Jian-Tai Timothy Qiu; Kuan-Chong Chao; Hua-Hsi Wu; Chi-Mu Chuang; Peng-Hui Wang; Chi-Ying F Huang
Journal:  PLoS One       Date:  2017-09-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.